We are live on !
Find out more
SCM
Stellar Capital Management Portfolio holdings
AUM
$147M
Turnover
11.54%
1-Year Est. Return
5.91%
This Fund
S&P 500
This Quarter Est. Return
+18.43%
1 Year Est. Return
+5.91%
3 Year Est. Return
+23.45%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$147M
AUM Growth
+$25.6M
(+21%)
Cap. Flow
+$5.08M
Cap. Flow % of AUM
Cap. Flow %
3.45%
Top 10 Holdings %
Top 10 Hldgs %
36.86%
Holding
78
New
6
Increased
35
Reduced
24
Closed
3
Avg Time Held
4.2
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
2.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$5.11M |
| 2 |
Principal Financial Group
PFG
|
+$1.84M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.04M |
| 4 |
Blackstone
BX
|
+$872K |
| 5 |
Invesco Senior Loan ETF
BKLN
|
+$357K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$4.18M |
| 2 |
HSBC
HSBC
|
+$1.96M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$302K |
| 4 |
Microsoft
MSFT
|
+$237K |
| 5 |
Vanguard Total International Bond ETF
BNDX
|
+$197K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.08% |
| 2 | Miscellaneous | 18.7% |
| 3 | Healthcare | 15.29% |
| 4 | Financials | 10.69% |
| 5 | Industrials | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Microsoft
MSFT
$3.96T
| $7.56M | 5.14% |
37,159
-1,308
| -3% | -$237K |
2013 Q4
26 quarters
|
|
2
Intel
INTC
$486B
| $7.42M | 5.04% |
123,983
-1,626
| -1% | -$97.2K |
2013 Q4
26 quarters
|
|
3
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$461M
| $6.05M | 4.11% |
115,158
+3,042
| +3% | +$153K |
2013 Q4
26 quarters
|
|
|
4
Invesco S&P 500 Equal Weight ETF
RSP
$98.6B
| $5.4M | 3.67% |
+53,025
| New | +$5.11M |
2020 Q2
0 quarters
|
|
5
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.17B
| $4.99M | 3.39% |
186,459
+8,293
| +5% | +$209K |
2015 Q4
18 quarters
|
|
6
Blackrock
BLK
$174B
| $4.9M | 3.33% |
9,015
+611
| +7% | +$309K |
2013 Q4
26 quarters
|
|
7
Thermo Fisher Scientific
TMO
$251B
| $4.81M | 3.27% |
13,273
+98
| +0.7% | +$32.8K |
2013 Q4
26 quarters
|
|
8
Merck
MRK
$354B
| $4.66M | 3.17% |
63,146
-200
| -0.3% | -$15.1K |
2013 Q4
26 quarters
|
|
9
Johnson & Johnson
JNJ
$612B
| $4.28M | 2.91% |
30,441
+659
| +2% | +$96K |
2013 Q4
26 quarters
|
|
10
Bank of America
BAC
$352B
| $4.16M | 2.83% |
175,220
+4,199
| +2% | +$99.2K |
2013 Q4
26 quarters
|
|
11
Accenture
ACN
$145B
| $3.96M | 2.69% |
18,434
+221
| +1% | +$41.8K |
2013 Q4
26 quarters
|
|
12
Global Payments
GPN
$22.4B
| $3.79M | 2.58% |
22,337
-505
| -2% | -$84.1K |
2013 Q4
26 quarters
|
|
13
Quest Diagnostics
DGX
$25.9B
| $3.71M | 2.52% |
32,535
+1,886
| +6% | +$200K |
2014 Q1
25 quarters
|
|
14
Alphabet (Google) Class C
GOOG
$4.16T
| $3.7M | 2.52% |
52,360
+920
| +2% | +$62.1K |
2013 Q4
26 quarters
|
|
|
15
Blackstone
BX
$85.5B
| $3.68M | 2.5% |
64,970
+16,561
| +34% | +$872K |
2019 Q3
3 quarters
|
|
16
Procter & Gamble
PG
$366B
| $3.64M | 2.47% |
30,429
+1,144
| +4% | +$133K |
2013 Q4
26 quarters
|
|
17
Alibaba
BABA
$270B
| $3.58M | 2.44% |
16,609
+216
| +1% | +$45K |
2019 Q3
3 quarters
|
|
18
Linde
LIN
$232B
| $3.45M | 2.34% |
16,251
-750
| -4% | -$145K |
2018 Q4
6 quarters
|
|
19
Oracle
ORCL
$393B
| $3.13M | 2.13% |
56,695
+3,595
| +7% | +$190K |
2013 Q4
26 quarters
|
|
20
Eaton
ETN
$152B
| $2.91M | 1.98% |
33,285
-740
| -2% | -$60.9K |
2013 Q4
26 quarters
|
|
|
21
Bristol-Myers Squibb
BMY
$120B
| $2.89M | 1.97% |
49,181
+17,307
| +54% | +$1.04M |
2019 Q3
3 quarters
|
|
22
W.P. Carey
WPC
$14.5B
| $2.75M | 1.87% |
41,506
-3
| -0% | -$186 |
2013 Q4
26 quarters
|
|
23
Blackstone Mortgage Trust
BXMT
$1.73B
| $2.73M | 1.86% |
113,430
+4,657
| +4% | +$107K |
2020 Q1
1 quarter
|
|
24
Broadcom
AVGO
$1.6T
| $2.72M | 1.85% |
86,200
+3,100
| +4% | +$86.8K |
2018 Q3
7 quarters
|
|
25
AT&T
T
$159B
| $2.68M | 1.82% |
117,513
+6,551
| +6% | +$149K |
2018 Q1
9 quarters
|
|
Similar funds
JT
BC
LI
SC
CCM
CCM
LM
HF
Stellar Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Stellar Capital Management held 78 positions worth $147M, up 21% from $122M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Stellar Capital Management deployed $5.08M of net new capital in Q2 2020, opening 6 new positions and adding to 35 existing holdings. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 53,025 shares worth $5.4M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $237K trimmed.
- Stellar Capital Management's largest Q2 2020 buy was Invesco S&P 500 Equal Weight ETF: 53,025 shares worth $5.4M.
- Stellar Capital Management added most to Bristol-Myers Squibb in Q2 2020, an estimated $1.04M increase.
- Stellar Capital Management's biggest Q2 2020 reduction was Microsoft, cutting an estimated $237K.
- Stellar Capital Management fully exited Vanguard FTSE Emerging Markets ETF in Q2 2020, selling an estimated $4.18M.
- Stellar Capital Management's ten largest holdings make up 37% of its $147M portfolio in Q2 2020.
- Stellar Capital Management opened 6 new positions and closed 3 in Q2 2020.
- Stellar Capital Management's portfolio value rose 21% quarter-over-quarter to $147M.
Based on Stellar Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.